Infants, Children, and the Zika Virus: What Primary Care Providers Need to Know
October 18, 2017
With the effects of Congenital Zika syndrome manifesting in infants as more than microcephaly, rather a pattern of congenital anomalies, including intracranial and other brain or eye anomalies, the Centers for Disease Control (CDC) recently updated guidelines for physicians monitoring the development of infants born to mothers with a possible Zika virus infection during pregnancy.
Included within this document are instructions for laboratory testing and follow up evaluation and care based on each patient’s lab results and observed conditions. The guidelines can be found in their entirety here on the CDC site.
Children’s National Congenital Zika Virus Program is poised to assist physicians with care for infants and children affected by Congenital Zika syndrome during infancy and throughout their childhood. The multidisciplinary team includes representatives from the Children’s National Complex Care Program available to provide comprehensive care coordination and help families with children affected by the syndrome—who may be medically complex, see multiple specialists, or are technology-dependent—navigate through the healthcare system.
In addition to complex care specialists, Children’s National has over 40 subspecialties under the same roof with top physicians available to work with you through the Congenital Zika Virus Program to provide your patients the best care for their specific conditions, including:
Physicians who have identified Zika-affected infants should contact the program at 202-476-7409 or visit ChildrensNational.org/Zika with questions, concerns, or referrals.